To Get Help Now
Click Here
 
Today's Date:

Health Canada Reviews Yaz and Yasmin For Risks

AddThis Social Bookmark Button

Health Canada is reviewing two studies recently published in the British Medical Journal which suggest that the risk of blood clots is higher with the drospirenone-containing Yaz and Yasmin birth control pills than older oral contraceptives containing levonorgestrel. Drospirenone is a synthetic version of progestin.

Though one well-known side effect risk of nearly all oral contraceptives is developing venous thromboembolism, the risks of blood clots when using Yaz and Yasmin are thought to be two-times to three-times higher than other contraceptives. The blood clots generally form in the leg but can move around the body and into lungs and form a potentially deadly pulmonary embolism.

Health Canada says it will complete the review then decide the appropriate action, including whether new physician and consumer safety information is warranted. Women who take Yaz or Yasmin and experience leg swelling, leg pain, chest pain or sudden loss of breath need to seek medical attention immediately.

breakinglawsuitnews.com disclaimer: This article: Health Canada Reviews Yaz and Yasmin For Risks was posted on Wednesday, June 8th, 2011 at 7:21 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.